PHARMACOKINETICS OF METRONIDAZOLE IN HEALTHY ADULT VOLUNTEERS AFTER TABLETS AND SUPPOSITORIES

被引:39
作者
BERGAN, T [1 ]
ARNOLD, E [1 ]
机构
[1] AS DUMEX,DEPT BIOL,COPENHAGEN,DENMARK
关键词
D O I
10.1159/000237911
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:231 / 241
页数:11
相关论文
共 15 条
  • [1] CONNOR TH, 1977, CANCER RES, V37, P629
  • [2] METABOLISM OF METRONIDAZOLE (1-2'-HYDROXYETHYL-2-METHYL-5-NITROIMIDAZOLE)
    INGS, RMJ
    LAW, GL
    PARNELL, EW
    [J]. BIOCHEMICAL PHARMACOLOGY, 1966, 15 (05) : 515 - &
  • [3] KANE PO, 1961, BRIT J VENER DIS, V37, P273
  • [4] ANTI-TRICHOMONAD ACTION, MUTAGENICITY, AND REDUCTION OF METRONIDAZOLE AND OTHER NITROIMIDAZOLES
    LINDMARK, DG
    MULLER, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (03) : 476 - 482
  • [5] MCFADZEAN JA, 1969, BRIT J VENER DIS, V45, P161
  • [6] MCGILVERAY IJ, 1978, INT J CLIN PHARM BI, V16, P110
  • [7] BIOAVAILABILITY OF METRONIDAZOLE IN FASTING AND NON-FASTING HEALTHY SUBJECTS AND IN PATIENTS WITH CROHNS-DISEASE
    MELANDER, A
    KAHLMETER, G
    KAMME, C
    URSING, B
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (01) : 69 - 72
  • [8] Monro A M, 1974, Curr Med Res Opin, V2, P130, DOI 10.1185/03007997409113627
  • [9] Nielsen M L, 1977, Scand J Gastroenterol, V12, P1003
  • [10] PHARMACOKINETICS OF METRONIDAZOLE AS DETERMINED BY BIOASSAY
    RALPH, ED
    CLARKE, JT
    LIBKE, RD
    LUTHY, RP
    KIRBY, WMM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (06) : 691 - 696